Clinical Trials Logo

Clinical Trial Summary

Description of the neurological impairment: clinico-radiological and electrophysilogical correlations


Clinical Trial Description

Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological, respiratory and dysautonomic Determine the prognosis of neurological damages to short and long term. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04460599
Study type Observational
Source Centre d'Investigation Clinique et Technologique 805
Contact David Orlikowski, MD PhD
Phone 0147107777
Email david.orlikowski@aphp.fr
Status Recruiting
Phase
Start date March 8, 2020
Completion date September 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT02538094 - tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis N/A
Completed NCT00381433 - Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid Phase 1
Completed NCT00031486 - Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir Phase 3
Completed NCT00069303 - Natural History of West Nile Virus Infection N/A
Completed NCT02906631 - Epidemiology and Prognosis of Encephalitis in Intensive Care
Completed NCT02367664 - A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants Phase 3
Completed NCT00314132 - Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. Phase 3
Terminated NCT00927953 - Treatment of West Nile Virus With MGAWN1 Phase 2
Recruiting NCT05393492 - Regulating Emotions and Behaviors After Brain Injury N/A
Terminated NCT04361344 - Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection N/A
Recruiting NCT04372615 - The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis Phase 2
Completed NCT02714959 - IL-2 in Refractory Autoimmune Encephalitis Phase 1/Phase 2
Completed NCT01092507 - A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers Phase 3
Completed NCT01041573 - Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population Phase 3
Not yet recruiting NCT04722328 - Establishment of Prevention and Control System of Central Nervous System Infection
Recruiting NCT06067750 - Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
Not yet recruiting NCT06368648 - CoMind Early Feasibility Study
Completed NCT02526550 - Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX Phase 4
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Completed NCT04080921 - Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis Phase 1/Phase 2